4.5 Article

Antisense transcripts are targets for activating small RNAs

Journal

NATURE STRUCTURAL & MOLECULAR BIOLOGY
Volume 15, Issue 8, Pages 842-848

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/nsmb.1444

Keywords

-

Funding

  1. NIBIB NIH HHS [EB 05556, F31 EB005556-02, F31 EB005556-01, F31 EB005556-03, F31 EB005556] Funding Source: Medline
  2. NIGMS NIH HHS [R01 GM077253, R01 GM060642, R01 GM073042-04, R01 GM060642-08, R01 GM077253-01A2, R01 GM073042] Funding Source: Medline
  3. PHS HHS [NIGMS 77253, NIGMS 73042, NIGMS 60642] Funding Source: Medline

Ask authors/readers for more resources

Agents that activate expression of specific genes to probe cellular pathways or alleviate disease would go beyond existing approaches for controlling gene expression. Duplex RNAs complementary to promoter regions can repress or activate gene expression. The mechanism of these promoter-directed antigene RNAs (agRNAs) has been obscure. Other work has revealed noncoding transcripts that overlap mRNAs. The function of these noncoding transcripts is also not understood. Here we link these two sets of enigmatic results. We find that antisense transcripts are the target for agRNAs that activate or repress expression of progesterone receptor (PR). agRNAs recruit Argonaute proteins to PR antisense transcripts and shift localization of the heterogeneous nuclear ribonucleoprotein-k, RNA polymerase II and heterochromatin protein 1 gamma. Our data demonstrate that antisense transcripts have a central role in recognition of the PR promoter by both activating and inhibitory agRNAs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available